Milind Deshpande Insider Trading
Get free email notifications about insider trading for Milind Deshpande.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Milind Deshpande. Milind Deshpande is an Chief Executive Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and a EVP and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and a Pres R&D and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and a President and CEO in ACHILLION PHARMACEUTICALS INC ($ACHN) and a President and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and a President of R&D and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and a SVP and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and a Director in Spero Therapeutics, Inc. ($SPRO).
Address: C/O ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN 06511 CT
Companies in which Milind Deshpande is an Insider
ACHILLION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Milind Deshpande: Chief Executive Officer, President and CEO, President and CSO, Pres R&D and CSO, President of R&D and CSO, EVP and CSO, SVP and CSO
Holdings: 2,500 shares
Current Value: $10,950
Latest Transaction: Feb 13 2018
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Spero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Milind Deshpande: Director
Holdings: 0 shares
Latest Transaction: Jan 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Milind Deshpande
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 17.93 | 2,629 | 47,138 | 2,629 | |
| Oct 27 2020 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 13.52 | 7,500 | 101,400 | 7,500 | |
| Jan 06 2020 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 9.87 | 5,408 | 53,377 | 5,408 | |
| Jun 05 2019 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 10.67 | 6,073 | 64,799 | 6,073 | |
| Jun 06 2018 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 11.54 | 6,073 | 70,082 | 6,073 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Option Exercise | A | 2.90 | 640,000 | 1,856,000 | 640,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Option Exercise | A | 4.11 | 458,000 | 1,882,380 | 458,000 |